Gene immunization may induce secondary antibodies reacting with DNA

Vaccine

Volumn 22, Issue 11-12, 2004, Pages 1576-1585

  Isaguliants, Maria G ^a,b   Iakimtchouk, Konstantin ^a,b   Petrakova, Natalia V ^b   Yermalovich, Marina A ^a   Zuber, Anne Kjerrström ^a   Kashuba, Vladimir I ^a   Belikov, Sergey V ^a   Andersson, Sören ^a,c   Kochetkov, Sergey N ^d   Klinman, Dennis M ^e   Wahren, Britta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c Örebro Läns Landsting ^*  (Sweden)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Aa; Amino acid(s); HCV; HIV 1; Human hepatitis C virus; Human immunodeficiency virus type 1; NDNA; OD; Optical density; Ribonuclear protein; RNP; SI; Single and double stranded DNA; SLE; Ss and dsDNA; Stimulation indice; Systemic lupus erythematosus

Indexed keywords

ADAPTOR PROTEIN; DNA ANTIBODY; DNA VACCINE; DOUBLE STRANDED DNA; EPITOPE; NUCLEIC ACID BINDING PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING;

ANIMALS; AUTOANTIBODIES; CHINCHILLA; CRITHIDIA; DNA; DNA, SINGLE-STRANDED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENES, NEF; GENES, VIRAL; HEPATITIS C ANTIGENS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; IMMUNOGLOBULINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RABBITS; VACCINES, DNA;

EID: 11144358505     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.09.033     Document Type: Article

References (51)

1. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:2000;927-974.
2. Pisetsky D.S. Specificity and immunochemical properties of antibodies to bacterial DNA. Methods. 11:1997;55-61.
3. MacGregor R.R., Boyer J.D., Ugen K.E.et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect Dis. 178(1):1998;92-100.
4. Calarota S., Bratt G., Nordlund S.et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients. Lancet. 351:1998;1320-1325.
5. MacGregor R.R., Boyer J.D., Ciccarelli R.B., Ginsberg R.S., Weiner D.B. Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data. J Infect Dis. 181:2000;406.
6. Mor G., Singla M., Steinberg A.D., Hoffman S.L., Okuda K., Klinman D.M. Do DNA vaccines induce autoimmune disease? Hum Gene Ther. 8:1997;293-300.
7. Hinkula J., Svanholm C., Schwartz S.et al. Recognition of prominent viral epitopes is induced by immunization with HIV-1 regulatory genes. J. Virol. 71:1997;5528-5539.
8. Inchaupse G., Vitvitski L., Major M.E.et al. Plasmid DNA expressing a secreted or a nonsecreted form of heptitis C virus nucleocapsid: comparative studies of antibody and T-helper cell responses following genetic immunization. DNA Cell Biol. 16:1997;185-195.
9. Isaguliants M.G., Petrakova N.V., Zuber B.et al. DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge. Intervirology. 43(4-6):2000;288-293.
10. Isenberg D.A., Rahman M.A., Ravirajan C.T., Kalsi J.K. Anti-DNA antibodies: from gene usage to crystal structure. Immunol Today. 18(4):1997;149-153.
11. van Venrooij W.J., Pruijn G.J. Ribonucleoprotein complexes as autoantigens. Curr Opin Immunol. 7:1995;819-824.
12. Scofield R.H., Dickey W.D., Jackson K.W., James J.A., Harley J.B. A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein. J Clin Immunol. 11(6):1991;378-388.
13. Moens U O.M., Hey A.W.et al. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc. Natl Acad. Sci USA. 92:1995;12393-12397.
14. Mouneaux F., Muller S. Epitope spreading in SLE: identification of triggering peptide sequences. Arthritis Rheum. 46(6):2002;1430-1438.
15. Bredholt G., Olaussen E., Moens U., Rekvig O.P. Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen: footprints of a common molecular and cellular process? Arthritis Rheum. 42(12):1999;2583-2592.
16. Kjerrstrom A., Hinkula J., Engstrom G.et al. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines. Virology. 284:2001;46-61.
17. Isaguliants M., Pokrovskaya K., Kashuba V.et al. Eukaryotic expression of enzymatically active HIV-1 reverse transcriptase. FEBS Lett. 447:1999;232-236.
18. Khudyakov Yu.E., Fields H.A., Favorov M.O., Khudyakova N.S., Bonafonte M.T., Holloway B. Synthetic gene for the hepatitis C virus nucleocapsid protein. Nucleic Acids Res. 21(11):1993;2747-2754.
19. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115:1991;887-903.
20. Sambrook J, Fritsch EF, Maniatis T, Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
21. Rechinsky V.O., Barbashov C.F., Dyagterev L.et al. Reverse transcriptase of HIV-1: cloning, expression in E. coli, purification of the enzyme, and production of monoclonal antibodies. Mol. Biol. (Russia). 25:1991;1248-1257.
22. Petrakova N.V., Kalinina T.I., Khudiakov I.E., Gazina E.V., Smirnov V.D. Preparation and purification of a polypeptide containing antigenic determinants of hepatitis C core protein. Vopr Virusol. (Russia). 42(5):1997;208-212.
23. Suzuki N., Harada T., Mizushima Y., Sakane T. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol. 151:1993;1128-1136.
24. Aarden L.A., DeGroot E.R., Feltkamp T.E.W. Immunology of DNA. III Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescent technique. Ann NY Acad Sci. 254:1975;505-515.
25. Smeenk R.J.T., van Brink H.G., Brinkman K., Termaat R.M., Berden J.H.M., Swaak A.J.G. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int. 11:1991;101-107.
26. Klinman D.M. Cross-reactivity of IgG and IgM secreting B cells in normal and autoimmune mice. J Autoimmun. 7(1):1994;1-11.
27. Kadlubowski M., Jackson M., Yap P.L., Neill G. Lack of specificity for antibodies to double stranded DNA found in four commercial kits. J Clin Pathol. 44(3):1991;246-250.
28. Gilkeson G.S., Ruiz P., Pippen A.M.M., Alexander A.L., Lefkowith J.B., Pisetsky D.S. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med. 183:1996;1389-1397.
29. Miller J.F. Self-nonself discrimination and tolerance in T and B lymphocytes. Immunol Res. 12(2):1993;115-130.
30. Fredriksen K., Osei A., Sundsfjord A., Traavik T., Rekvig O. On the biological origin of anti-double stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice. Eur J Immunol. 24(1):1994;66-70.
31. Kim B., Loeb L.A. Human immunodeficiency virus type-1 reverse transcriptase substitutes for DNA polymerase I in Escherichia coli. Proc Natl Acad Sci USA. 92:1995;684-688.
32. Arion D., Harada R., Li X., Wainberg M.A., Parniak M.A. HIV-1 reverse transcriptase shows no specificity for binding of primer tRNA (Lys3). Biochem Biophys Res Comm. 225:1996;839-843.
33. Arts E.J., Le Grice S.F. Interaction of retroviral reverse transcriptase with template-primer duplexes during replication. Prog Nucleic Acids Res Mol Biol. 58:1998;339-393.
34. Echarri A., Gonzalez M.E., Carrasco L. The N-terminal Arg-rich region of HIV types 1 and 2 and SIV Nef is involved in RNA binding. Eur J Biochem. 246:1997;38-44.
35. Karn T., Hock B., Holtrich U., Adamski M., Strebhardt K., Rubsamen-Waigmann H. Isolation of a novel Nef binding factor with characteristics of an adaptor protein. Virology. 246:1998;45-52.
36. Shimoike T., Mimori S., Tani H., Matsuura Y., Miyamura T. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol. 73:1999;9718-9725.
37. Li D., Takyar S.T., Lott W.B., Gowans E.J. Amino acids 1-20 of the HCV core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells. J Gen Virol. 84(4):2003;815-825.
38. Riedl P., Stober D., Oehninger C., Melber K., Reimann J., Schirmbeck R. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J Immunol. 168(10):2002;4951-4959.
39. Mamula M. Epitope spreading: the role of self peptides and autoantigen processing by B-lymphocytes. Immunol Rev. 164:1998;231-239.
40. Birnbaum F., Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol. 64:1995;3319-3330.
41. Kunkel M., Lorinczi M., Rijnbrand R., Lemon S.M., Watowich S.J. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol. 75(5):2001;2119-2129.
42. Marchini B., Puccetti A., Dolcher M.P., Madaio M.P., Migliorini P. Induction of anti-DNA antibodies in non autoimmune mice by immunization with a DNA-DNAase I complex. Clin Exp Rheumatol. 13(1):1995;7-10.
43. Desai D.D., Krishnan M.R., Swindle J.T., Marion T.N. Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. Immunology. 151:1993;1614-1626.
44. James J.A., Gross T., Scolfield R.H., Harley J.B. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med. 181:1995;453-461.
45. Moens U., Mathiesen I., Ghelue M.V., Rekvig O.P. Green fluorescent protein modified to bind DNA initiates production of anti-DNA antibodies when expressed in vivo. Mol Immunol. 38:2002;505-514.
46. Bloom D.D., Davignon J.L., Cohen P.L., Eisenberg R.A., Clarke S.H. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J Immunol. 150:1993;1579-1590.
47. Zack D.J., Yamamoto K., Wong A.L., Stempniak M., French C., Weisbart R.H. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupis erythematosus. J. Immunol. 154(4):1995;1987-1994.
48. Gaynor B., Putterman C., Valadon P., Spatz L., Scharff M.D., Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc. Natl. Acad. Sci USA. 94:1997;1955-1960.
49. Pisetsky D.S., Gilkeson G., Clair E.W.St. Systemic lupus erythematosus: diagnosis and treatment. Med. Clin. North Am. 81:1997;113-128.
50. Lefkowith J.B., Gilkeson G.S. Nephritogenic autoantibodies in lupus: current concepts and continuing contraversies. Arthritis Rheum. 39:1996;894-903.
51. Moss K.E., Ioannou Y., Sultan S.M., Haq I., Isenberg D.A. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 61:2002;409-413.